|
Originally published In Press as doi:10.1074/jbc.M311786200 on February 19, 2004
J. Biol. Chem., Vol. 279, Issue 17, 18091-18097, April 23, 2004
In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions*
Feng Miao,
Irene Gaw Gonzalo,
Linda Lanting, and
Rama Natarajan
From the
Gonda Diabetes Center, Beckman Research Institute of City of Hope, Duarte, California 91010
The transcription factor NF- B (NF- B) plays a pivotal role in regulating inflammatory gene expression. Its effects are optimized by various coactivators including histone acetyltransferases (HATs) such as CBP/p300 and p/CAF. Evidence shows that high glucose (HG) conditions mimicking diabetes can activate the transcription of NF- B-regulated inflammatory genes. However, the underlying in vivo transcription and nuclear chromatin remodeling events are unknown. We therefore carried out chromatin immunoprecipitation (ChIP) assays in monocytes to identify 1) chromatin factors bound to the promoters of tumor necrosis factor- (TNF- ) and related NF- B-regulated genes under HG or diabetic conditions, 2) specific lysine (Lys (K)) residues on histone H3 (HH3) and HH4 acetylated in this process. HG treatment of THP-1 monocytes increased the transcriptional activity of NF- B p65, which was augmented by CBP/p300 and p/CAF. ChIP assays showed that HG increased the recruitment of NF- B p65, CPB, and p/CAF to the TNF- and COX-2 promoters. Interestingly, ChIP assays also demonstrated concomitant acetylation of HH3 at Lys9 and Lys14, and HH4 at Lys5, Lys8, and Lys12 at the TNF- and COX-2 promoters. Overexpression of histone deacetylase (HDAC) isoforms inhibited p65-mediated TNF- transcription. In contrast, a HDAC inhibitor stimulated gene transcription and histone acetylation. Finally, we demonstrated increased HH3 acetylation at TNF- and COX-2 promoters in human blood monocytes from type 1 and type 2 diabetic subjects relative to nondiabetic. These results show for the first time that diabetic conditions can increase in vivo recruitment of NF- B and HATs, as well as histone acetylation at the promoters of inflammatory genes, leading to chromatin remodeling and transcription.
Received for publication, October 27, 2003
, and in revised form, February 4, 2004.
* This work was supported by National Institutes of Health Grants RO1 DK065073 and PO1 HL55798, by Juvenile Diabetes Foundation International, and in part by General Clinical Research Center Grant MO1RR00043 (awarded to City of Hope) from the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Gonda Diabetes Center, Beckman Research Inst. of the City of Hope, 1500 East Duarte Rd., Duarte, CA 91010. Tel.: 626-359-8111 (ext. 62289); Fax: 626-301-8136; E-mail: rnatarajan{at}coh.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Eur. Heart J.,
February 1, 2009;
30(3):
266 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Nacci, M. Tarquinio, L. De Benedictis, A. Mauro, A. Zigrino, M. R. Carratu, M. J. Quon, and M. Montagnani
Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes Is Opposed by Compensatory Overexpression of Cyclooxygenase-2 in the Vasculature
Endocrinology,
February 1, 2009;
150(2):
849 - 861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Degner, A. J. Papoutsis, O. Selmin, and D. F. Romagnolo
Targeting of Aryl Hydrocarbon Receptor-Mediated Activation of Cyclooxygenase-2 Expression by the Indole-3-Carbinol Metabolite 3,3'-Diindolylmethane in Breast Cancer Cells
J. Nutr.,
January 1, 2009;
139(1):
26 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Miao, D. D. Smith, L. Zhang, A. Min, W. Feng, and R. Natarajan
Lymphocytes From Patients With Type 1 Diabetes Display a Distinct Profile of Chromatin Histone H3 Lysine 9 Dimethylation: An Epigenetic Study in Diabetes
Diabetes,
December 1, 2008;
57(12):
3189 - 3198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P. L. Jones, R. G. Roeder, M. E. Cooper, and M. Brownlee
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
J. Exp. Med.,
September 29, 2008;
205(10):
2409 - 2417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, M. A. Reddy, F. Miao, N. Shanmugam, J.-K. Yee, D. Hawkins, B. Ren, and R. Natarajan
Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-{kappa}B-dependent Inflammatory Genes: RELEVANCE TO DIABETES AND INFLAMMATION
J. Biol. Chem.,
September 26, 2008;
283(39):
26771 - 26781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Reddy, L. M. Villeneuve, M. Wang, L. Lanting, and R. Natarajan
Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice
Circ. Res.,
September 12, 2008;
103(6):
615 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Clarke, A. Sutcliffe, K. Deacon, D. Bradbury, L. Corbett, and A. J. Knox
PKC{beta}II Augments NF-{kappa}B-Dependent Transcription at the CCL11 Promoter via p300/CBP-Associated Factor Recruitment and Histone H4 Acetylation
J. Immunol.,
September 1, 2008;
181(5):
3503 - 3514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Brunn, S. Saadi, and J. L. Platt
Constitutive Repression of Interleukin-1{alpha} in Endothelial Cells
Circ. Res.,
April 11, 2008;
102(7):
823 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Nakamura, I. Matsushita, E. Kosaka, T. Kondo, and T. Kimura
Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells
Rheumatology,
April 1, 2008;
47(4):
418 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Johnson and R. I. Tapping
Microbial Products Stimulate Human Toll-like Receptor 2 Expression through Histone Modification Surrounding a Proximal NF-{kappa}B-binding Site
J. Biol. Chem.,
October 26, 2007;
282(43):
31197 - 31205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Gazzar, B. K. Yoza, J. Y.-Q. Hu, S. L. Cousart, and C. E. McCall
Epigenetic Silencing of Tumor Necrosis Factor {alpha} during Endotoxin Tolerance
J. Biol. Chem.,
September 14, 2007;
282(37):
26857 - 26864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yamini, X. Yu, M. E. Dolan, M. H. Wu, D. W. Kufe, and R. R. Weichselbaum
Inhibition of Nuclear Factor-{kappa}B Activity by Temozolomide Involves O6-Methylguanine Induced Inhibition of p65 DNA Binding
Cancer Res.,
July 15, 2007;
67(14):
6889 - 6898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Sullivan, A. B. M. Reddy, K. Dietzmann, A. R. Suriano, V. P. Kocieda, M. Stewart, and M. Bhatia
Epigenetic Regulation of Tumor Necrosis Factor Alpha
Mol. Cell. Biol.,
July 15, 2007;
27(14):
5147 - 5160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Miao, X. Wu, L. Zhang, Y.-C. Yuan, A. D. Riggs, and R. Natarajan
Genome-wide Analysis of Histone Lysine Methylation Variations Caused by Diabetic Conditions in Human Monocytes
J. Biol. Chem.,
May 4, 2007;
282(18):
13854 - 13863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, J. J. Rossi, and R. Natarajan
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors
PNAS,
February 27, 2007;
104(9):
3432 - 3437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-l. Li, M. A. Reddy, Q. Cai, L. Meng, H. Yuan, L. Lanting, and R. Natarajan
Enhanced Proatherogenic Responses in Macrophages and Vascular Smooth Muscle Cells Derived From Diabetic db/db Mice
Diabetes,
September 1, 2006;
55(9):
2611 - 2619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pestka and H.-R. Zhou
Toll-Like Receptor Priming Sensitizes Macrophages to Proinflammatory Cytokine Gene Induction by Deoxynivalenol and Other Toxicants
Toxicol. Sci.,
August 1, 2006;
92(2):
445 - 455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Miao, S. Li, V. Chavez, L. Lanting, and R. Natarajan
Coactivator-Associated Arginine Methyltransferase-1 Enhances Nuclear Factor-{kappa}B-Mediated Gene Transcription through Methylation of Histone H3 at Arginine 17
Mol. Endocrinol.,
July 1, 2006;
20(7):
1562 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Szulakowski, A. J. L. Crowther, L. A. Jimenez, K. Donaldson, R. Mayer, T. B. Leonard, W. MacNee, and E. M. Drost
The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2006;
174(1):
41 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Das, A. Kumar, Z. Lin, W. D. Patino, P. M. Hwang, M. W. Feinberg, P. K. Majumder, and M. K. Jain
Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes
PNAS,
April 25, 2006;
103(17):
6653 - 6658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Fish, C. C. Matouk, A. Rachlis, S. Lin, S. C. Tai, C. D'Abreo, and P. A. Marsden
The Expression of Endothelial Nitric-oxide Synthase Is Controlled by a Cell-specific Histone Code
J. Biol. Chem.,
July 1, 2005;
280(26):
24824 - 24838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Miao and R. Natarajan
Mapping Global Histone Methylation Patterns in the Coding Regions of Human Genes
Mol. Cell. Biol.,
June 1, 2005;
25(11):
4650 - 4661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Wood, V. L. Nelson-Degrave, E. Jansen, J. M. McAllister, S. Mosselman, and J. F. Strauss III
Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects
Physiol Genomics,
February 10, 2005;
20(3):
233 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Natarajan and J. L. Nadler
Lipid Inflammatory Mediators in Diabetic Vascular Disease
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2004;
24(9):
1542 - 1548.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|